logo

Inovio Pharmaceuticals Inc. (INO)



Trade INO now with
  Date
  Headline
8/4/2021 8:02:09 AM INOVIO Doses First Participant In Phase 2 Trial For DNA Vaccine Against Middle East Respiratory Syndrome
6/3/2021 8:04:26 AM Geneos Therapeutics Reports Positive Preliminary Results Of Its Ongoing First-in-human Trial
5/17/2021 8:02:45 AM INOVIO Announces Appointment Of Roger Dansey To Board
5/10/2021 4:42:08 PM INOVIO Q1 Total Revenue $371K Vs $1.3 Mln Last Year
5/10/2021 4:07:12 PM INOVIO Q1 Loss/Shr $0.27 Vs Loss $0.26 Last Year
4/23/2021 8:09:13 AM INOVIO Plans For Predominantly Ex-U.S. Phase 3 Trial For COVID-19 Vaccine Candidate, INO-4800
4/15/2021 8:09:10 AM INOVIO Announces Results Of Study Focusing On Human Immune Responses Induced By DNA Vaccine Candidate For COVID-19
3/15/2021 8:02:26 AM INOVIO Names Michael Cordera As EVP & General Counsel
2/24/2021 1:50:32 AM INOVIO, QIAGEN Collaborate To Develop Next Generation Sequencing Companion Diagnostic For INOVIO's VGX-3100
2/23/2021 8:04:09 AM INOVIO Reports First Dose In Phase 1B Clinical Trial For DNA Vaccine Against Lassa Fever, INO-4500, In West Africa